RANDALL BERLINER: Open Payments
NPI 1962469809 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,752 in 114 payments from 23 companies in 2025. Trend: 2023 $10,848 · 2024 $5,516 · 2025 $2,752
Food & beverage: $2,752
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $499 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $323 |
| Lundbeck LLC | 13 | $319 |
| Amgen Inc. | 11 | $276 |
| Teva Pharmaceuticals USA, Inc. | 9 | $265 |
| PFIZER INC. | 13 | $201 |
| Genentech USA, Inc. | 4 | $97 |
| ACADIA Pharmaceuticals Inc | 4 | $96 |
| Eisai Inc. | 3 | $70 |
| Averitas Pharma Inc. | 2 | $69 |
Products named: CAPLYTA, REXULTI, VYEPTI, UPLIZNA, NURTEC ODT, ABILIFY MAINTENA, UZEDY, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
